← peptides typeshit

Peter Attia traces 25 gray-market peptides back to big pharma patents

Attia's team challenges the claim that peptides like BPC-157 and TB-500 can't be patented, mapping each compound's patent and drug development history.

Read at Peter Attia MD

Recap by typeshit. Full story at Peter Attia MD.